# Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa

> **NCT00100646** · NA · COMPLETED · sponsor: **The Wistar Institute** · enrollment: 30 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BEHAVIORAL:** Structured treatment interruption
- **DRUG:** Lamivudine
- **DRUG:** Lopinavir/Ritonavir
- **DRUG:** Stavudine
- **BIOLOGICAL:** Rabies de novo antigen

## Key facts

- **NCT ID:** NCT00100646
- **Lead sponsor:** The Wistar Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100646, "Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00100646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*